Evidence map›Paper›PMID 28981893›Full record

ArticleNucleic acids research2017

Ritornello: high fidelity control-free chromatin immunoprecipitation peak calling.

Kelly P Stanton, Jiaqi Jin, Roy R Lederman, Sherman M Weissman, Yuval Kluger

Abstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kelly P StantonDepartment of Pathology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
Jiaqi JinDepartment of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
Roy R LedermanProgram of Applied Mathematics, Yale University, 51 Prospect Street, New Haven, CT 06511, USA.
Sherman M WeissmanDepartment of Genetics, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.
Yuval KlugerDepartment of Pathology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.

Funding

EFFICIENT SPECTRAL APPROACHES FOR FINDING UNDERLYING STRUCTURES IN BIG DATAR01HG008383 · NHGRI · YALE UNIVERSITY · PI KLUGER, YUVAL · 2016 to 2018
$1.2M
NHGRI NIH HHS R01 HG008383
6 · The paper itself

Abstract

With the advent of next generation high-throughput DNA sequencing technologies, omics experiments have become the mainstay for studying diverse biological effects on a genome wide scale. Chromatin immunoprecipitation (ChIP-seq) is the omics technique that enables genome wide localization of transcription factor (TF) binding or epigenetic modification events. Since the inception of ChIP-seq in 2007, many methods have been developed to infer ChIP-target binding loci from the resultant reads after mapping them to a reference genome. However, interpreting these data has proven challenging, and as such these algorithms have several shortcomings, including susceptibility to false positives due to artifactual peaks, poor localization of binding sites and the requirement for a total DNA input control which increases the cost of performing these experiments. We present Ritornello, a new approach for finding TF-binding sites in ChIP-seq, with roots in digital signal processing that addresses all of these problems. We show that Ritornello generally performs equally or better than the peak callers tested and recommended by the ENCODE consortium, but in contrast, Ritornello does not require a matched total DNA input control to avoid false positives, effectively decreasing the sequencing cost to perform ChIP-seq. Ritornello is freely available at https://github.com/KlugerLab/Ritornello.

Indexed as

SoftwareAlgorithmsArtifactsBinding SitesChromatin ImmunoprecipitationDNAHigh-Throughput Nucleotide SequencingNucleotide MotifsSequence Analysis, DNATranscription FactorsDNATranscription Factors

Identifiers

PMID28981893
PMCPMC5716106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.